Stem cell rejuvenation pathway points to new periodontal bone repair strategy

Periodontitis is one of the most common chronic diseases on the planet, and its signature damage is deceptively quiet: the gradual destruction of the bone and soft tissues that anchor teeth in the jaw. Once that supporting architecture erodes, it rarely rebuilds itself, and age makes the problem worse. The stem cells that normally orchestrate repair in the periodontium lose their vigor over time, becoming senescent, less proliferative, and less capable of laying down new bone. Now a research team at Sichuan University reports that a single secreted protein, insulin-like growth factor binding protein 5, or IGFBP5, can reverse many of these aging-related deficits in dental follicle stem cells, and that packaging the rejuvenated cells inside an engineered hydrogel measurably improves bone regeneration in a rat model of periodontitis. The work, led by Professor Jun Liu of the Department of Orthodontics at West China Hospital of Stomatology, was published online in Volume 18 of the International Journal of Oral Science on September 15, 2026.

The starting point for the study was a deceptively simple observation problem. Dental follicle stem cells, or DFSCs, are considered strong candidates for periodontal tissue engineering because they are accessible, expandable in culture, and naturally inclined toward the lineages needed to rebuild tooth-supporting structures. Yet like all adult stem cells, they accumulate damage with passaging and environmental stress. The team therefore asked a question that sits at the intersection of stem cell biology and regenerative dentistry: what molecular changes accompany DFSC senescence, and can any of them be reversed before the cells are transplanted into a patient?

To answer it, the researchers pushed human DFSCs into senescence in two distinct ways. One cohort was subjected to oxidative stress, mimicking the inflammatory environment of a diseased periodontal pocket, while another was driven into replicative senescence through repeated rounds of cell division. Gene-expression profiling and protein analyses then revealed a dramatic pattern: IGFBP5 expression collapsed in both models, falling by more than fivefold under oxidative stress and by a striking 69-fold during replicative senescence. The senescent cells simultaneously displayed elevated reactive oxygen species, impaired viability and migration, and weakened osteogenic differentiation, confirming that the aging process was compromising exactly the functions a therapeutic cell population would need.

What happened when the researchers restored IGFBP5 is the heart of the study. Reintroducing the protein counteracted several hallmarks of senescence at once: senescence-associated molecular changes diminished, reactive oxygen species levels dropped, cell-cycle activity improved, and markers of bone formation rebounded in the stressed cells. “We found that restoring IGFBP5 could counter several features of stem cell senescence,” says Prof. Liu. “Improvements in cell survival and bone-forming ability suggested that IGFBP5 may help preserve the regenerative function of DFSCs during aging.” In other words, a single binding protein appeared to act as a gatekeeper for the regenerative identity of these cells.

The mechanistic trail then led the team into Wnt signaling territory, one of the most consequential regulatory networks in developmental and stem cell biology. Gene-expression analysis pointed to the non-canonical Wnt pathway, rather than the classical Wnt/beta-catenin arm, as the relevant branch. IGFBP5 overexpression reduced levels of WNT5B and the transcription factor c-Jun, while canonical pathway components remained largely unchanged. Follow-up experiments sharpened the causal picture: adding WNT5B externally weakened the bone-forming benefits conferred by IGFBP5 and increased a cellular senescence marker, whereas blocking WNT5B partially rescued both the senescent phenotype and the osteogenic defects of replicatively aged cells. Together, the data suggest that IGFBP5 sustains the function of aging DFSCs at least partly by suppressing WNT5B-related signaling, positioning the IGFBP5-WNT5B axis as a regulatory circuit with real therapeutic leverage.

Translating a molecular discovery into a usable therapy requires more than a protein target; it requires a delivery vehicle that can keep engineered cells alive in the harsh environment of a periodontal defect. The Sichuan team addressed this with a composite scaffold called Gel-vHA@oe-DFSC. The system weaves three components together: a gelatin methacryloyl, or GelMA, hydrogel that provides a biocompatible three-dimensional matrix; vinyl-functionalized nanohydroxyapatite, a bone-mimetic mineral phase that supports osteoconductivity; and DFSCs genetically engineered to overexpress IGFBP5. In laboratory testing, the hydrogel supported cell survival under oxidative stress, promoted healthy cell spreading, and enhanced osteogenic activity, indicating that the material itself was actively contributing to the regenerative environment rather than merely holding cells in place.

The decisive test came in rats with experimentally induced periodontitis. When the IGFBP5-overexpressing cell-laden hydrogel was applied to periodontal defects, the treated animals showed improved alveolar bone quality, with measurable increases in bone mineral density and bone volume fraction. Histological examination of the regenerated tissue revealed less inflammation and better collagen organization than in controls, suggesting that the treatment did not simply deposit mineral but fostered structurally more faithful repair. “Our results suggest that rejuvenating therapeutic stem cells before delivery may be more effective than simply transplanting untreated cells,” says Prof. Liu. “The scaffold also provides a way to support these modified cells at the periodontal defect site while they promote local tissue repair.”

The implications of the study extend well beyond dentistry. Cellular senescence is a central obstacle in regenerative medicine generally, limiting the efficacy of stem cell therapies for bone, cartilage, skin, and other tissues in older patients. If IGFBP5 proves to be a generalizable marker and modulator of stem cell aging, it could serve a dual role: as a molecular indicator used to quality-control cell products before transplantation, and as a target for pre-treatment rejuvenation strategies. The findings also add momentum to the growing field of hydrogel-based cell delivery, where biomaterials are increasingly designed to do more than carry cargo, actively participating in the signaling dialogue that determines whether transplanted cells survive, integrate, and differentiate.

The authors are careful to frame the work as a foundation rather than a finished therapy. The experiments were conducted in human cell lines in vitro and in a rat model, and the researchers note that additional studies are needed in cells derived from older patients and in larger animal models before any clinical application can be contemplated. Questions about the long-term behavior of IGFBP5-overexpressing cells, the optimal dosing of the pathway modulation, and the safety of genetic engineering in therapeutic contexts all remain open. Still, the study is notable for the completeness of its arc, moving from a senescence phenotype, through gene-expression discovery and mechanistic validation, to a biomaterial delivery system and an in vivo demonstration of efficacy.

For the millions of people whose teeth are loosened by age-related periodontal bone loss, the prospect of regenerating the damaged foundation rather than merely slowing its decline remains a distant but increasingly credible goal. What this study contributes is a concrete molecular handle, IGFBP5 and its suppression of WNT5B signaling, and a practical delivery platform that pairs rejuvenated stem cells with a bone-mimetic hydrogel. By demonstrating that treating the cells before they are transplanted can outperform simply transplanting them, the Sichuan team has articulated a principle that could reshape how regenerative dentistry, and perhaps regenerative medicine more broadly, thinks about the aging of its most important raw material. The work was supported by the National Natural Science Foundation of China and the Sichuan Science and Technology Program, and the authors declare no competing interests.

Subject of Research: IGFBP5-mediated rejuvenation of dental follicle stem cells for periodontal bone regeneration

Article Title: A stem cell pathway offers a new route to periodontal bone regeneration

Article References: A stem cell pathway offers a new route to periodontal bone regeneration. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: periodontitis, dental follicle stem cells, IGFBP5, WNT5B, cellular senescence, bone regeneration, hydrogel, GelMA, nanohydroxyapatite, regenerative medicine, Sichuan University, non-canonical Wnt pathway